Mcewen Mining INC Form 4 insider transactions

McEwen Inc. Director John Casimir Florek acquired 585 deferred stock units, increasing his beneficial ownership to 1,311 units.

McEwen Inc.'s General Counsel, Carmen L. Diges, reported recent acquisitions of common stock and vesting of restricted stock units.

McEwen Inc. Director Dalia Nadine Asterbadi reported the acquisition of 585 deferred stock units, increasing her beneficial ownership to 1,311 units.

McEwen Inc.'s General Counsel, Carmen L. Diges, filed an amended Form 4 to correct stock option and common stock holdings following a 10-for-1 reverse stock split.

McEwen Inc.'s Chairman and CEO, Robert Ross McEwen, filed an amended Form 4 to correct previously reported stock option exercises and sales, adjusting for a 10-for-1 reverse stock split.

McEwen Inc. Director Richard W. Brissenden exercised stock options and subsequently sold a portion of the acquired common stock on September 22, 2025.

Jeffrey Chan, VP of Finance at McEwen Inc., executed a planned transaction involving the exercise of stock options and subsequent sale of common stock.

McEwen Inc.'s General Counsel, Carmen L. Diges, exercised stock options and subsequently sold a portion of the acquired shares.

McEwen Inc.'s Chairman and CEO, Robert Ross McEwen, exercised stock options and subsequently sold a portion of the acquired shares.

McEwen Inc.'s Chairman and CEO, Robert Ross McEwen, increased his indirect beneficial ownership by 53,160 common shares through a loan conversion related to McEwen Copper Inc.

McEwen Inc. Director Stephen Douglas Kaszas acquired 726 deferred stock units, which are fully vested and convertible into common stock.

McEwen Inc. Director Dalia Nadine Asterbadi reported the acquisition of 726 fully vested Deferred Stock Units, convertible to common stock upon service termination.

McEwen Inc. Director John Casimir Florek acquired 726 deferred stock units, aligning his interests with shareholders.

McEwen Inc. Chief Operating Officer William M. Shaver was granted 2,600 Restricted Stock Units, vesting in installments through June 2026.

McEwen Inc.'s Chief Financial Officer, Perry Ing, was granted 2,400 restricted stock units as part of an equity compensation plan.

McEwen Inc.'s VP of Corporate Development, Stephan Michael Spears, was granted 1,500 restricted stock units with a future vesting schedule.

McEwen Inc. awarded 1,600 Restricted Stock Units to Carmen L. Diges, General Counsel and Corporate Secretary, vesting in installments through June 2026.

Jeffrey Chan, VP of Finance at McEwen Inc., was granted 1,600 Restricted Stock Units, vesting in installments through June 2026.

McEwen Inc. Director Ian J. Ball sold 2,656 shares of common stock for $10.49 per share, reducing his direct beneficial ownership to zero.

McEwen Inc.'s VP of Corporate Development, Stephan Michael Spears, was granted 40,000 stock options and 3,600 restricted stock units.

McEwen Inc. Director Richard W. Brissenden was granted 20,000 stock options with an exercise price of $10.43, vesting over three years.

McEwen Inc.'s General Counsel, Carmen L. Diges, was granted 40,000 stock options and 3,900 restricted stock units.

McEwen Inc. Director Michael Nelson Melanson received a grant of 10,000 stock options with an exercise price of $10.43, vesting in three equal annual installments.

McEwen Inc. Director Dalia Nadine Asterbadi was granted 10,000 stock options with an exercise price of $10.43, vesting over three years.

McEwen Inc.'s Chief Operating Officer and Director, William M. Shaver, was granted 80,000 stock options and 6,300 restricted stock units.

McEwen Inc. Director John Casimir Florek was granted 10,000 stock options with an exercise price of $10.43, vesting over three years.

McEwen Inc. Director Nicolas Darveau-Garneau was granted 20,000 stock options with an exercise price of $10.43, vesting annually starting August 2026.

McEwen Inc.'s Chief Financial Officer, Perry Ing, was granted 50,000 stock options and 5,600 restricted stock units, aligning executive incentives with shareholder value.

McEwen Inc. Director Alfred Aguilar Colas was granted 10,000 stock options with an exercise price of $10.43, vesting over three years.

McEwen Inc. Director Stephen Douglas Kaszas was granted 10,000 stock options with an exercise price of $10.43, vesting over three years.